APA (7th ed.) Citation

Wilbraham, D., Berg, P. H., Tsai, M., Liffick, E., Loo, L. S., Doty, E. G., & Sellers, E. (2020). Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study. Journal of clinical pharmacology, 60(4), 495-504. https://doi.org/10.1002/jcph.1543

Chicago Style (17th ed.) Citation

Wilbraham, Darren, Paul H. Berg, Max Tsai, Emily Liffick, Li Shen Loo, Erin Gautier Doty, and Edward Sellers. "Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study." Journal of Clinical Pharmacology 60, no. 4 (2020): 495-504. https://doi.org/10.1002/jcph.1543.

MLA (9th ed.) Citation

Wilbraham, Darren, et al. "Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study." Journal of Clinical Pharmacology, vol. 60, no. 4, 2020, pp. 495-504, https://doi.org/10.1002/jcph.1543.